Caroline Piatek

1.1k total citations
40 papers, 623 citations indexed

About

Caroline Piatek is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, Caroline Piatek has authored 40 papers receiving a total of 623 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hematology, 20 papers in Immunology and 17 papers in Genetics. Recurrent topics in Caroline Piatek's work include Complement system in diseases (17 papers), Blood groups and transfusion (13 papers) and Renal Diseases and Glomerulopathies (11 papers). Caroline Piatek is often cited by papers focused on Complement system in diseases (17 papers), Blood groups and transfusion (13 papers) and Renal Diseases and Glomerulopathies (11 papers). Caroline Piatek collaborates with scholars based in United States, France and United Kingdom. Caroline Piatek's co-authors include Casey L. O’Connell, Alexander Röth, Austin Kulasekararaj, Anna Gayà, Stephan Ortiz, Richard A. Wells, Saskia Langemeijer, Emilio Ojeda Gutierrez, Jong Wook Lee and Régis Peffault de Latour and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Caroline Piatek

36 papers receiving 610 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Caroline Piatek United States 11 334 247 203 193 75 40 623
Kirsten L. Rose United Kingdom 6 678 2.0× 227 0.9× 394 1.9× 92 0.5× 71 0.9× 7 742
Fanny Tabarin France 5 268 0.8× 191 0.8× 184 0.9× 79 0.4× 101 1.3× 7 540
Claire Hall United Kingdom 6 575 1.7× 296 1.2× 328 1.6× 201 1.0× 41 0.5× 6 692
Mustafa Nuri Yenerel Türkiye 10 100 0.3× 192 0.8× 80 0.4× 81 0.4× 33 0.4× 42 375
Chiharu Sugimori Japan 14 435 1.3× 525 2.1× 128 0.6× 146 0.8× 44 0.6× 34 739
Morag Griffin United Kingdom 14 630 1.9× 311 1.3× 368 1.8× 269 1.4× 45 0.6× 75 761
Anthony Nicholls United Kingdom 5 423 1.3× 200 0.8× 237 1.2× 80 0.4× 46 0.6× 8 590
Haraldine A. Stafford United States 12 327 1.0× 117 0.5× 56 0.3× 63 0.3× 63 0.8× 22 578
Elisabetta Valoti Italy 13 1.1k 3.2× 429 1.7× 844 4.2× 157 0.8× 104 1.4× 21 1.2k
Josephine M. I. Vos Netherlands 13 171 0.5× 297 1.2× 68 0.3× 372 1.9× 98 1.3× 63 753

Countries citing papers authored by Caroline Piatek

Since Specialization
Citations

This map shows the geographic impact of Caroline Piatek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline Piatek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline Piatek more than expected).

Fields of papers citing papers by Caroline Piatek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caroline Piatek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline Piatek. The network helps show where Caroline Piatek may publish in the future.

Co-authorship network of co-authors of Caroline Piatek

This figure shows the co-authorship network connecting the top 25 collaborators of Caroline Piatek. A scholar is included among the top collaborators of Caroline Piatek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caroline Piatek. Caroline Piatek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kulasekararaj, Austin, Robert A. Brodsky, Hubert Schrezenmeier, et al.. (2025). Ravulizumab demonstrates long-term efficacy, safety and favorable patient survival in patients with paroxysmal nocturnal hemoglobinuria. Annals of Hematology. 104(1). 81–94. 2 indexed citations
2.
Kulasekararaj, Austin, Jong Wook Lee, Christopher J. Patriquin, et al.. (2025). Characterizing clinically significant extravascular hemolysis in adults with PNH on ravulizumab or eculizumab treatment. Blood Advances. 9(19). 4936–4945.
3.
Piatek, Caroline, Jong Wook Lee, Morag Griffin, et al.. (2024). Danicopan As Add-on Therapy to Ravulizumab or Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria: Long-Term Patient-Reported Outcomes from the Phase 3 ALPHA Trial. Blood. 144(Supplement 1). 2692–2692. 1 indexed citations
4.
Broome, Catherine M., Donald M. Arnold, Caroline Piatek, et al.. (2023). PB2554: DESIGN OF A PHASE 1B OPEN-LABEL STUDY TO ASSESS THE SAFETY, EFFICACY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF POVETACICEPT (ALPN-303) IN SUBJECTS WITH AUTOIMMUNE CYTOPENIAS (RUBY-4). HemaSphere. 7(S3). e691820b–e691820b. 1 indexed citations
5.
Kuter, David J., et al.. (2023). Fostamatinib for warm antibody autoimmune hemolytic anemia: Phase 3, randomized, double‐blind, placebo‐controlled, global study (FORWARD). American Journal of Hematology. 99(1). 79–87. 18 indexed citations
6.
Piatek, Caroline, Flore Sicre de Fontbrune, Fahri Şahin, et al.. (2023). Efficacy and Safety of Subcutaneous Ravulizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria Who Received Prior Intravenous Eculizumab: 2-Year Follow-up. Blood. 142(Supplement 1). 2713–2713. 1 indexed citations
7.
8.
Yenerel, Mustafa Nuri, Flore Sicre de Fontbrune, Caroline Piatek, et al.. (2022). Phase 3 Study of Subcutaneous Versus Intravenous Ravulizumab in Eculizumab-Experienced Adult Patients with PNH: Primary Analysis and 1-Year Follow-Up. Advances in Therapy. 40(1). 211–232. 17 indexed citations
9.
Pai, Jonathan, et al.. (2021). Improving Delays in Obtaining Lenalidomide at a Large Safety Net Hospital. Blood. 138(Supplement 1). 1925–1925.
10.
Peipert, John Devin, Austin Kulasekararaj, Anna Gayà, et al.. (2020). Patient preferences and quality of life implications of ravulizumab (every 8 weeks) and eculizumab (every 2 weeks) for the treatment of paroxysmal nocturnal hemoglobinuria. PLoS ONE. 15(9). e0237497–e0237497. 34 indexed citations
11.
12.
Kulasekararaj, Austin, Anita Hill, Saskia Langemeijer, et al.. (2019). One-Year Efficacy and Safety from a Phase 3 Trial of Ravulizumab in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria Receiving Prior Eculizumab Treatment. Blood. 134(Supplement_1). 2231–2231. 5 indexed citations
13.
Pan, Elizabeth, et al.. (2018). Case Report: Oxaliplatin-Induced Immune-Mediated Thrombocytopenia. Case Reports in Oncology. 11(3). 880–882. 4 indexed citations
14.
Kulasekararaj, Austin, Anita Hill, Scott T. Rottinghaus, et al.. (2018). Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor–experienced adult patients with PNH: the 302 study. Blood. 133(6). 540–549. 256 indexed citations
15.
Piatek, Caroline, Vinod Pullarkat, Imran Siddiqi, et al.. (2017). Autoimmune Myelofibrosis: Clinical Features, Course, and Outcome. Acta Haematologica. 138(3). 129–137. 18 indexed citations
16.
Piatek, Caroline, Scott T. Tagawa, Diana L. Hanna, et al.. (2016). OC-14 - Baseline D-dimer levels are predictive of recurrent venous thromboembolism (VTE) at 6 months in cancer patients with VTE treated with tinzaparin. Thrombosis Research. 140. S174–S174. 3 indexed citations
17.
Piatek, Caroline, Ihab El‐Hemaidi, Donald I. Feinstein, Howard A. Liebman, & Mojtaba Akhtari. (2015). Management of immune-mediated cytopenias in pregnancy. Autoimmunity Reviews. 14(9). 806–811. 11 indexed citations
18.
Piatek, Caroline, Vinod Pullarkat, Imran Siddiqi, et al.. (2014). Autoimmune myelofibrosis: an update on morphologic features in 29 cases and review of the literature. Human Pathology. 45(11). 2183–2191. 47 indexed citations
19.
Piatek, Caroline & Casey L. O’Connell. (2012). Unsuspected pulmonary embolism. Current Opinion in Pulmonary Medicine. 18(5). 406–409. 7 indexed citations
20.
Piatek, Caroline, Casey L. O’Connell, & Howard A. Liebman. (2012). Treating venous thromboembolism in patients with cancer. Expert Review of Hematology. 5(2). 201–209. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kirsten L. Rose Breakdown of academic impact, for papers by Fanny Tabarin Breakdown of academic impact, for papers by Claire Hall Breakdown of academic impact, for papers by Mustafa Nuri Yenerel Breakdown of academic impact, for papers by Chiharu Sugimori Breakdown of academic impact, for papers by Morag Griffin Breakdown of academic impact, for papers by Anthony Nicholls Breakdown of academic impact, for papers by Haraldine A. Stafford Breakdown of academic impact, for papers by Elisabetta Valoti Breakdown of academic impact, for papers by Josephine M. I. Vos
Rankless by CCL
2026